ASRT (assertiotx.com) Bozor qiymatining balans qiymatiga nisbati
Assertio Holdings, Inc. (ASRT) miya bilan bog'liq dori vositalari portfelini barqarorlashtirmoqda va tashqi inqirozlarni yumshatish uchun pul oqimini 2.01 darajasida saqlab qolishda sotib olingan aktivlardan foydalanmoqda. Biroq, biznes arzon generik dori vositalari va qarz bosimi tufayli xavflarga duch kelmoqda. Tarixiy narxlar dinamikasi emitentning bozoridagi tez-tez uchraydigan tebranishlarni aks ettiradi. Bundan tashqari, patent muddatining tugashi va potentsial mualliflik huquqi bilan bog'liq sud jarayonlari daromadlarni cheklamoqda.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ASRT_-_Assertio-Holdings-Inc._-_Capitalization-to-Book-Value-Ratio "ASRT Assertio Therapeutics Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 27.06.2026) | 👁️GURU.Markets👁️")
Assertio Holdings, Inc. (ASRT) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Assertio Holdings, Inc.|ASRT - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati assertiotx.com|ASRT - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Assertio Therapeutics|ASRT - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Assertio
Kompaniyaning dastlabki tahlili:Assertio Holdings - ASRT
Ushbu koeffitsiyent barcha aksiyalarning umumiy bozor kapitalizatsiyasini kapital miqdoriga bo'lish orqali hisoblanadi. Ushbu koeffitsiyentning barqarorligi biznesning yetuklik bosqichini tasdiqlab, ishonchlilikni yoki o'sish drayverlarining yetishmasligini anglatadi. Assertio Holdings, Inc. (ASRT) uchun logistika va dori-darmon zaxiralarini boshqarish samaradorligi sof aktivlar qiymatiga bevosita ta'sir ko'rsatadi. Bozor qiymatining buxgalteriya qiymatiga nisbati tendentsiyasini tahlil qilish kompaniyaning moddiy resurslaridan yuqori bo'lgan bozor premiumini baholash imkonini beradi.
Toʻgʻridan-toʻgʻri raqobatchilar
BIIB - Kapitallashuvning sof aktivlarga nisbati|NBIX (neurocrine.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TRVI|PRAX (Praxis Precision Medicines, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi AVXL (Anavex)|Bozor qiymatining balans qiymatiga nisbati CBLL|Balans qiymatiga nisbatan bozor kapitallashuvi Prothena PRTA|ALEC (Alector Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati omeros.com OMER|Balans qiymatiga nisbatan bozor qiymati Neurogene Inc|AC Immune Corp (ACIU) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Voyager Corp|NMRA (Neumora Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SCLX (scilexholding.com)|TVGN: Bozor qiymatining balans qiymatiga nisbati|ACOG - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Cognition Therapeutics, Inc. (CGTX)|IKT - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati Cassava Sciences, Inc. SAVA|COYA (Coya Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati VTGN (VistaGen Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti OVID|Bozor qiymatining balans qiymatiga nisbati Acumen Pharma (ABOS)|Bozor qiymatining balans qiymatiga nisbati CervoMed Corporation (CRVO)|ATHE - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Clene Inc CLNN|Bozor kapitallashuvining balans qiymatiga nisbati PEPG (PepGen Corp)|JUNS: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Relmada|Annovis Bio Corporation (ANVS) - Kapitallashuvning balans qiymatiga nisbati|Grace Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati AIFF|KLTO (Klotho Neurosciences Inc) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi neurosense-tx.com NRSN|Kapitallashuvning sof aktivlarga nisbati Reviva Pharmaceuticals Holdings|Balans qiymatiga nisbatan bozor qiymati MetaVia Inc. MTVA|Bozor kapitallashuvining balans qiymatiga nisbati NRXS (NeurAxis, Inc.)|HSDT: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati passagebio.com|Neuphoria Therapeutics (NEUP) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NERV|Kapitallashuvning sof aktivlarga nisbati Athira Pharma Corp (ATHA)|ADXN (Addex Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi alzamend.com (ALZN)|Bozor kapitallashuvining balans qiymatiga nisbati CYCN (Cyclerion Therapeutics, Inc.)|Protagenic Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati KTTA (Pasithea)|CRGT: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Avenue Therapeutics ATXI|Balans qiymatiga nisbatan bozor qiymati brainstorm-cell.com|Cara Therapeutics (CARA) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori CHRO|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics ELYM|Kapitallashuvning balans qiymatiga nisbati intracellulartherapies.com (ITCI)|LBPH: Bozor kapitallashuvining balans qiymatiga nisbati|MRNS - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGen Biotech - Kapitallashuvning sof aktivlarga nisbati|NRBO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Sage Therapeutics, Inc SAGE|SNPX (Synaptogenix, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati TRVN (Trevena, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Bozor kapitallashuvining balans qiymatiga nisbati CERE (Cerevel Therapeutics Inc)